Oxbow Advisors, LLC Bristol Myers Squibb CO Transaction History

Oxbow Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$48.48 - $57.85 $3.69 Million - $4.41 Million	76,201 New	76,201 $3.91 Million
Q3 2019 Oct 31, 2019	SELL	$42.77 - $50.71 $990,211 - $1.17 Million	-23,152 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $1.51 Million - $1.67 Million	-33,764 Reduced 59.32%	23,152 $1.05 Million
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $138,292 - $164,897	3,065 Added 5.69%	56,916 $2.72 Million
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $1.75 Million - $2.27 Million	35,956 Added 200.93%	53,851 $2.8 Million
Q3 2018 Nov 06, 2018	BUY	$55.19 - $62.25 $987,625 - $1.11 Million	17,895 New	17,895 $1.11 Million

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Oxbow Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Oxbow Advisors, LLC with notifications on news.